ZENSUN (SHANGHAI) SCI & TECH CO.
Zensun (Shanghai) Sci & Tech Co., Ltd. is a biopharmaceutical company focusing on the development of innovative ‘first in class’ bio-therapeutic products for the treatment of serious and life-threatening unmet medical needs. They discover new medicines using novel disease specific targets and innovative technologies. The patented discoveries are then developed into therapies. With adherence to the tenet of “healing for life”, we hope to transform the lives of heart failure and cancer patients by providing them with drugs that treat their disease and not the symptoms. Zensun’s current pipeline covers cardiovascular disease treatment, anti-cancer drugs, and treatments for energy metabolism disorders.
ZENSUN (SHANGHAI) SCI & TECH CO.
Industry:
Biopharma Biotechnology
Founded:
2000-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.zensunus.com
Total Employee:
1+
Status:
Active
Contact:
+86-21-50802627
Email Addresses:
[email protected]
Total Funding:
507 M CNY
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Mobile Non Scaleable Content ASP.NET Japanese Yen HiChina DNS China Telecom
Similar Organizations
Akari Therapeutics
Akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics.
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Kamada
Kamada is a biopharmaceutical company engaged in developing, producing and marketing of specialty life-saving therapeutics, using a unique
Silenseed
Silenseed is a biopharmaceutical company that focuses on the development of cancer therapies.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Founder
Investors List
SDIC Fund Management
SDIC Fund Management investment in Venture Round - Zensun (Shanghai) Sci & Tech Co.
China Everbright Ivy Capital Investment
China Everbright Ivy Capital Investment investment in Venture Round - Zensun (Shanghai) Sci & Tech Co.
Orient Securities
Orient Securities investment in Venture Round - Zensun (Shanghai) Sci & Tech Co.
TFTR Investment
TFTR Investment investment in Venture Round - Zensun (Shanghai) Sci & Tech Co.
China Venture Capital
China Venture Capital investment in Venture Round - Zensun (Shanghai) Sci & Tech Co.
More informations about "Zensun (Shanghai) Sci & Tech Co."
泽生科技
A Leading Chinese Biotech Company Developing Novel Medicines as First-in-Class for Global MarketSee details»
泽生科技 - zensunus.com
Innovation | Globalization I Focus. Zensun has been focused on R&D of original innovative medicine since founded and has built a product portfolio including novel therapeutics with new drug targets, new mechanisms, and new …See details»
泽生科技 - zensunus.com
周明东. 公司创始人，总经理，首席科学家. Introduction： 上海泽生科技开发股份有限公司董事长、总经理及首席科学家。 从事心脏发育、结构与功能相关的分子生物学研究逾30年，为这一 …See details»
Zensun USA Inc.
Apr 1, 2014 Zensun is a biopharmaceutical company focused on the development of innovative ‘first in class’ bio-therapeutic products for the treatment of serious and life-threatening unmet …See details»
Zensun USA, Inc. Company Profile | San Diego, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Zensun USA, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
ZENSUN USA, INC. | LinkedIn
ZENSUN USA, INC. | 113 followers on LinkedIn. Zensun is a biopharmaceutical company focused on the development of innovative ‘first in class’ bio-therapeutic products for the treatment of ...See details»
Zensun Company Profile | Management and Employees List
Zensun Profile and History. Zensun is a biopharmaceutical company focused on the development of innovative first in class bio-therapeutic products for the treatment of serious and life …See details»
Zensun (Shanghai) Sci & Tech Co. - Crunchbase
When was the last funding round for Zensun (Shanghai) Sci & Tech Co.? Zensun (Shanghai) Sci & Tech Co. closed its last funding round on Nov 16, 2017 from a Venture - Series Unknown …See details»
Zensun Announces the Investigation of Neucardin for Chronic …
Aug 28, 2019 SAN DIEGO, CA / ACCESSWIRE / August 28, 2019 / Zensun USA, Inc., a wholly-owned subsidiary of Zensun Sci & Tech Co. Ltd., Shanghai, announced that the investigation …See details»
Zensun Announces the Investigation of Neucardin for Chronic …
SAN DIEGO, August 28, 2019 (Newswire.com) - Zensun USA, Inc., a wholly-owned subsidiary of Zensun Sci & Tech Co. Ltd., Shanghai, announced that the investigation of NEUCARDIN , its …See details»
Zensun Company Profile - Office Locations, Competitors, Revenue …
See insights on Zensun including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Zensun Enterprises Limited
The Bell Ringing Ceremony of GMR (Zensun's US Company) at NYSE. Our REITs. DOWNLOADSSee details»
泽生科技 - zensunus.com
For past twenty years, Zensun has focused on the research of ErbB receptor family, RTKs and their downstream-activated signaling pathways and has tried to find out the relationship …See details»
泽生科技 - zensunus.com
Since its inception, Zensun has focused on the development of innovative bio-therapeutic products. During the research, the ErbB4 signaling pathway has been found playing a critical …See details»
Zensun Sci & Tech Co., Ltd. | Insights
Dec 19, 2017 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Working at Zensun USA - Glassdoor
Zensun is a biopharmaceutical company focused on the development of innovative ‘first in class’ bio-therapeutic products for the treatment of serious and life-threatening unmet medical needs.See details»
Zensun Announces the Investigation of Neucardin for Chronic …
Aug 28, 2019 SAN DIEGO, CA / ACCESSWIRE / August 28, 2019 / Zensun USA, Inc., a wholly-owned subsidiary of Zensun Sci & Tech Co. Ltd., Shanghai, announced that the investigation …See details»
Zensun Announces the Investigation of Neucardin for Chronic …
SAN DIEGO, August 28, 2019 (Newswire.com) - Zensun USA, Inc., a wholly-owned subsidiary of Zensun Sci & Tech Co. Ltd., Shanghai, announced that the investigation of NEUCARDIN ®, …See details»
Zensun Announces Positive Clinical Results for Neucardin™ to …
May 24, 2013 Global Phase 2 Clinical Trial Results for Neucardin ™. Six-hundred and seventy-eight people with CHF have participated in the Neucardin ™ clinical studies. Overall, the …See details»
泽生科技 - zensunus.com
Zensun has uncovered the critical role NRG-1 and its receptor ErbB4/2 plays in the adult heart, including the promotion of cell growth and survival, the maintenance of sarcomeric structural …See details»